Saneca Pharmaceuticals has been acquired by AZC Group
Eterus Capital, a.s. has sold Saneca Pharmaceuticals, a.s. to AZC Group.
Saneca is a pharmaceutical contract manufacturing company active in the development, production, registration and distribution of generic medicines and active pharmaceutical ingredients. Saneca also owns a portfolio of cosmetics and generic products.
Based in Slovakia, AZC is an industrial business group operating in over 20 countries.
Founded in 2008, Eterus Capital is an investor targeting small and medium-sized companies with growth potential, that have successfully proved their business concept. The fund only invests in minority positions, while management control always remains in the hands of the original shareholders.
Oaklins’ team in Slovakia acted as the exclusive sell-side advisor in this transaction.
Talk to the deal team
Related deals
Ñaming, SL has been acquired by DeA Capital S.p.A.
Spain’s leading producer of sandwiches, fresh and ultra-fresh products, Ñaming, has sold a majority stake to Italian fund DeA Capital.
Learn moreUniKidz has partnered with Karmijn Kapitaal
Karmijn Kapitaal has acquired a majority stake in UniKidz, a talent development organization that provides a scientifically-based developmental approach through high-quality childcare. Through the partnership with Karmijn Kapitaal, UniKidz can take the next step in bringing their unique concept to even more children.
Learn moreINNOTEX has been acquired by Clearspring Capital Partners
INNOTEX, a manufacturer of personal protective equipment for firefighters and first responders, has completed a strategic partnership with Clearspring Capital Partners.
Learn more